Skip to main content
OpenTrials

Clinical trial condition

Stage IV Colon Cancer AJCC v8

Explore clinical trials studying Stage IV Colon Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

13 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Colon Cancer AJCC v8 trial results

Recruiting

Family Communications After Genetic Testing

NCT07143487

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +25 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 276 locations
View Trial Details
Recruiting

Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery

NCT05296681

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +13 more
Locations
  • Robert Wood Johnson University Hospital, Hamilton Hamilton, New Jersey, United States
  • Monmouth Medical Center Lakewood, New Jersey, United States
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States
  • Cooperman Barnabas Medical Center Livingston, New Jersey, United States
View Trial Details
Completed

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

NCT04109924

Conditions
Advanced Colorectal Carcinoma, Colonic Diseases, Colonic Neoplasms, +37 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation

NCT05308446

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +18 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Mercy Cancer Center - Carmichael Carmichael, California, United States
  • Mercy San Juan Medical Center Carmichael, California, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 286 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details

Related conditions